Interventional radiologists have confirmed the effectiveness of a liver cancer treatment that has shown results were chemotherapy has failed. Treating liver tumors with higher doses of intra-arterial yttrium-90 radioembolization, which can be done on an outpatient basis, was shown to be effective and help preserve the patient’s quality of life, according to a study presented this week at the Society of Interventional Radiology’s 36th annual scientific meeting in Chicago.
Interventional radiologists have confirmed the effectiveness of a liver cancer treatment that has shown results where chemotherapy has failed. Treating liver tumors with higher doses of intra-arterial yttrium-90 radioembolization, which can be done on an outpatient basis, was shown to be effective and help preserve the patient’s quality of life, according to a study presented this week at the Society of Interventional Radiology’s 36th annual scientific meeting in Chicago.
"We knew that this unique interventional radiology treatment, done on an outpatient basis, which combines the radioactive isotope Y-90 into microspheres (small beads about the width of five red blood cells) that deliver radiation directly to a tumor, was one of the best ways to give patients a treatment that doesn't harm healthy cells," Riad Salem, MD, MBA, FSIR, professor of radiology, medicine, and surgery, and director of interventional oncology at Northwestern University’s radiology department, said in a statement.
"Now we know that patients can actually tolerate much higher doses of radiation than previously thought, which provides results in patients progressing on standard chemotherapy," he said.
Patients aren’t cured, but their lives are being extended and quality of life improved, he said.
In the four-year study, researchers looked at 151 patients with liver metastases from colorectal, neuroendocrine, and other cancers. Surgical removal of liver tumors is the best option, Salem said, but most patients aren’t candidates, and chemo becomes less effective as the disease progresses. In this study, patients showed high rates of “progression-free survival,” reasearchers said.
Here’s how the Y-90 radioembolization treatment works. The microspheres are injected through a catheter from the groin, and the beads become lodged within the tumor vessels where they cause cell death. This technique allows for a higher, local dose of radiation, with no danger from radiation to the healthy tissue in the body, according to Salem.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.